Logo image of CWD

CALIBERCOS INC (CWD) Stock Fundamental Analysis

NASDAQ:CWD - Nasdaq - US13000T1097 - Common Stock - Currency: USD

0.615  -0.02 (-2.38%)

Fundamental Rating

3

Taking everything into account, CWD scores 3 out of 10 in our fundamental rating. CWD was compared to 225 industry peers in the Capital Markets industry. While CWD seems to be doing ok healthwise, there are quite some concerns on its profitability. CWD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CWD has reported negative net income.
CWD had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CWD reported negative net income in multiple years.
CWD had negative operating cash flow in 4 of the past 5 years.
CWD Yearly Net Income VS EBIT VS OCF VS FCFCWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

CWD's Return On Assets of -6.69% is on the low side compared to the rest of the industry. CWD is outperformed by 87.21% of its industry peers.
Industry RankSector Rank
ROA -6.69%
ROE N/A
ROIC N/A
ROA(3y)-1.26%
ROA(5y)-0.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWD Yearly ROA, ROE, ROICCWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

CWD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWD Yearly Profit, Operating, Gross MarginsCWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for CWD has been reduced compared to 1 year ago.
CWD has a worse debt/assets ratio than last year.
CWD Yearly Shares OutstandingCWD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M
CWD Yearly Total Debt VS Total AssetsCWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.25, we must say that CWD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.25, CWD is not doing good in the industry: 74.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACCN/A
WACCN/A
CWD Yearly LT Debt VS Equity VS FCFCWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 7.17 indicates that CWD has no problem at all paying its short term obligations.
CWD has a Current ratio of 7.17. This is amongst the best in the industry. CWD outperforms 89.95% of its industry peers.
CWD has a Quick Ratio of 7.16. This indicates that CWD is financially healthy and has no problem in meeting its short term obligations.
CWD has a Quick ratio of 7.16. This is amongst the best in the industry. CWD outperforms 89.95% of its industry peers.
Industry RankSector Rank
Current Ratio 7.17
Quick Ratio 7.16
CWD Yearly Current Assets VS Current LiabilitesCWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.86% over the past year.
CWD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.97%.
Measured over the past years, CWD shows a very strong growth in Revenue. The Revenue has been growing by 33.83% on average per year.
EPS 1Y (TTM)21.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.2%
Revenue 1Y (TTM)-24.97%
Revenue growth 3Y33.83%
Revenue growth 5YN/A
Sales Q2Q%-33.63%

3.2 Future

CWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.89% yearly.
The Revenue is expected to grow by 37.50% on average over the next years. This is a very strong growth
EPS Next Y30.71%
EPS Next 2Y31.2%
EPS Next 3Y26.89%
EPS Next 5YN/A
Revenue Next Year41.64%
Revenue Next 2Y40.27%
Revenue Next 3Y37.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CWD Yearly Revenue VS EstimatesCWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
CWD Yearly EPS VS EstimatesCWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CWD. In the last year negative earnings were reported.
Also next year CWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWD Price Earnings VS Forward Price EarningsCWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWD Per share dataCWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as CWD's earnings are expected to grow with 26.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.2%
EPS Next 3Y26.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIBERCOS INC

NASDAQ:CWD (2/21/2025, 8:11:28 PM)

0.615

-0.02 (-2.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-20 2025-03-20/amc
Inst Owners4.6%
Inst Owner Change-58.58%
Ins Owners28.57%
Ins Owner Change0.14%
Market Cap13.82M
Analysts80
Price Target3.57 (480.49%)
Short Float %0.26%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.8%
Min EPS beat(2)-98.02%
Max EPS beat(2)107.62%
EPS beat(4)2
Avg EPS beat(4)-186.39%
Min EPS beat(4)-791.09%
Max EPS beat(4)107.62%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)50.23%
Min Revenue beat(2)19.82%
Max Revenue beat(2)80.63%
Revenue beat(4)4
Avg Revenue beat(4)176.85%
Min Revenue beat(4)19.82%
Max Revenue beat(4)458.16%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)16.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS2.95
BVpS-0.17
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.26%
ROA(5y)-0.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.17
Quick Ratio 7.16
Altman-Z 0.25
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.2%
EPS Next Y30.71%
EPS Next 2Y31.2%
EPS Next 3Y26.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.97%
Revenue growth 3Y33.83%
Revenue growth 5YN/A
Sales Q2Q%-33.63%
Revenue Next Year41.64%
Revenue Next 2Y40.27%
Revenue Next 3Y37.5%
Revenue Next 5YN/A
EBIT growth 1Y45.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.07%
OCF growth 3YN/A
OCF growth 5YN/A